Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy.
Dong MH, Mei ZC, Zhou LQ, Heming M, Xu LL, Liu YX, Pang XW, Chu YH, Cai SB, Ye H, Shang K, Xiao J, Meyer Zu Hörste G, Wang W, Qin C, Tian DS.
Dong MH, et al. Among authors: chu yh.
Med. 2025 May 16:100704. doi: 10.1016/j.medj.2025.100704. Online ahead of print.
Med. 2025.
PMID: 40425008
Free article.